Moayeri Sharon E, Coutre Steven E, Ramirez Edward J, Westphal Lynn M
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Stanford Hospital, Stanford, CA, USA.
Am J Obstet Gynecol. 2007 Apr;196(4):e10-1. doi: 10.1016/j.ajog.2007.01.025.
A 34-year-old nulligravid woman experienced hemorrhage after each of 2 oocyte retrievals. Initial coagulopathy screening was negative. Treatments used during in vitro fertilization likely interfered with assay performance. Reevaluation remote from medications confirmed the diagnosis of von Willebrand disease. Treatments used during in vitro fertilization may increase bleeding risk and confound coagulopathy evaluation.